Inventor · disambiguated record
Susanne Mangold
Also filed as: MANGOLD SUSANNE
10 granted patents·12 pending applications·138 citations·filing 2004–2025
89Inventor score
Top patents by PatentIndex Score
22 records- 0195US11472886B2Cross-species-specific PSMAxCD3 bispecific single chain antibodyAMGEN RES MUNICH GMBH·Filed 2021·Granted Oct 18, 2022·3 cites·13 claims
- 0292US9982063B2Pharmaceutical compositions with resistance to soluble CEAAMGEN RES MUNICH GMBH·Filed 2016·Granted May 29, 2018·14 cites·25 claims
- 0392US8784821B1Human-anti-human cd3 binding moleculesKUFER PETER·Filed 2004·Granted Jul 22, 2014·63 cites·23 claims
- 0490US9587036B2Cross-species-specific PSMAxCD3 bispecific single chain antibodyKUFER PETER·Filed 2011·Granted Mar 7, 2017·24 cites·34 claims
- 0588US11987633B2Cross-species-specific single domain bispecific single chain antibodyAMGEN RES MUNICH GMBH·Filed 2021·Granted May 21, 2024·1 cites·27 claims
- 0687US8394926B2Pharmaceutical compositions with resistance to soluble CEALUTTERBUESE RALF·Filed 2006·Granted Mar 12, 2013·21 cites·34 claims
- 0785US10981998B2Cross-species-specific single domain bispecific single chain antibodyKUFER PETER·Filed 2009·Granted Apr 20, 2021·5 cites·18 claims
- 0880US9695250B2Pharmaceutical compositions with resistance to soluble CEAAMGEN RES MUNICH GMBH·Filed 2013·Granted Jul 4, 2017·4 cites·19 claims
- 0977US8901278B2Pharmaceutical antibody compositions with resistance to soluble CEARAU DORIS·Filed 2011·Granted Dec 2, 2014·3 cites·2 claims
- 1075US12281172B2Cross-species-specific PSMAxCD3 bispecific single chain antibodyAMGEN RES MUNICH GMBH·Filed 2021·Granted Apr 22, 2025·0 cites·18 claims
- 1174US2025163179A1CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODYAMGEN RES MUNICH GMBH·Filed 2025·Application pending·0 cites
- 1267US2011293619A1CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODYKUFER PETER·Filed 2009·Application pending·0 cites
- 1364US2020095319A1Cross-species-specific bispecific bindersAMGEN RES MUNICH GMBH·Filed 2019·Application pending·0 cites
- 1464US2023357444A1Cross-species-specific binding domainAMGEN RES MUNICH GMBH·Filed 2022·Application pending·0 cites
- 1563US2010183615A1Cross-species-specific bispecific bindersMICROMET AG·Filed 2008·Application pending·0 cites
- 1661US2020362039A1Cross-species-specific pscaxcd3, cd19xcd3, c-metxcd3, endosialinxcd3, epcamxcd3, igf-1rxcd3 or fapalphaxcd3 bispecific single chain antibodyAMGEN RES MUNICH GMBH·Filed 2019·Application pending·0 cites
- 1761US2019169310A1CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODYAMGEN RES MUNICH GMBH·Filed 2018·Application pending·0 cites
- 1859US2012034228A1CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODYKUFER PETER·Filed 2009·Application pending·0 cites
- 1956US2012244162A1Cross-species-specific bispecific bindersKUFER PETER·Filed 2012·Application pending·0 cites
- 2054US2009226444A1Pharmaceutical antibody compositions with resistance to soluble ceaMICROMET AG·Filed 2006·Application pending·0 cites
- 2153US2016152707A1Cross-species-specific bispecific bindersAMGEN RES MUNICH GMBH·Filed 2015·Application pending·0 cites
- 2249US2010150918A1Cross-species-specific binding domainMICROMET AG·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Susanne Mangold files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →